Lupin Gets CDSCO Panel Nod To study osteoporosis drug Denosumab Dr. Divya Colin4 Aug 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Mansukh Mandaviya calls for mandatory adoption of Good Manufacturing Practices by all pharma companies Ruchika Sharma3 Aug 2023 3:30 PM ISTObservations from ongoing risk-based inspections further reiterated the need to have a re-look at the current GMP regulations and quality management...
Bid to buy Glenmark Life for Rs 7000 crore: Nirma leads acquisition race with ChrysCap, Sekhmet Farhat Nasim2 Aug 2023 5:43 PM ISTNew Delhi: Leading the race to acquire Glenmark Life Sciences in a deal that could cost around Rs 7000 crore, Nirma Group has emerged as the...
Serum Institute Of India Gets CDSCO Panel Nod To study Dengue Tetravalent Vaccine Dr. Divya Colin1 Aug 2023 6:00 PM ISTNew Delhi: Vaccine major Serum Institute of India has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags Adverse Reactions Linked To Colistimethate Sodium Susmita Roy31 July 2023 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that...
Submit Phase III clinical trial report up to 180 days: CDSCO Panel Tells Bharat Biotech on Oral Cholera Vaccine Dr. Divya Colin30 July 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the vaccine maker Bharat Biotech to manufacture Cholera Vaccine (Inactivated, Oral), the Subject...
Zydus Lifesciences gets CDSCO panel nod to manufacture, market Relugolix Tablets Dr. Divya Colin29 July 2023 6:00 PM ISTNew Delhi: Noting an unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Cipla promoters in talk with Blackstone, Baring Asia for stake sale: Report Farhat Nasim28 July 2023 7:10 PM ISTNew Delhi: Top promoters of drug giant Cipla are in talks with private equity players including Blackstone and Baring Asia to sell a part of their...
Ensure safety, efficacy of applied Synthetic product: CDSCO panel Tells Sun Pharma for Liraglutide Injection Dr. Divya Colin27 July 2023 6:00 PM ISTNew Delhi: Rejecting the request presented by drug major Sun Pharma for a clinical trial waiver for glucagon-like peptide-1 analog Liraglutide...
Akums Gets CDSCO panel Nod To Manufacture, Market Bisoprolol Fumarate Dr. Divya Colin26 July 2023 6:00 PM ISTNew Delhi: Considering the request of the drug major Akum Pharmaceuticals for a bioequivalence study (BE) and clinical trial waiver, the Subject...
Roche Gets CDSCO Nod To Study Anticancer FDC Drug Dr. Divya Colin25 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central...
AiMeD demands separate law for regulation of medical device industry, writes to Mandaviya opposing new regulatory Bill Farhat Nasim24 July 2023 6:16 PM ISTNew Delhi: Upset over the draft of the New Drugs, Medical Devices and Cosmetics Bill, 2023 being listed to be presented in Parliament in the monsoon...
